Replies to post #344644 on Amarin Corp Plc (AMRN)

[johngnatt]

So that what is the case Amarin is fighting?

Hikma has insulated them from any induced infringement claim. Does Hikma's reliance on FDA AB rating enough to convince the judge?


@marjac Regarding the generic, I posted under @captbeer 's post.

Since Hikma has posted the MSDS sheet on their website, we have to assume it is true.

They are selling a misbranded drug. No evidence need to be provided. There is no way that with 80% as the max (100% pure content of EPA), they can have a bioequivalent product.